The Biotechnology Industry By Richard Graydon, M.D.

The primary goal of the biotechnology industry is to invent new biologically-active substances, for the treatment of disease, the pharmaceutical industry, and the management of agriculture.

The U.S. is the world leader in biotechnology, currently providing employment for more than 300,000 people in over 6,000 U.S. biotech companies, with an estimated market capitalization of approximately USD 281 billion in 2008. The biotechnology industry has more than tripled in size since 2000, with revenues increasing from USD 25 billion in 2000 to more than USD 80 billion in 2008. In 2007, Amgen, Inc., the world's largest biotechnology company, achieved total sales of USD 14.7 billion. Expectations are that the biotechnology market will increase to more than USD 130 billion by 2011.

Geographically, the U.S. accounts for 65% of the biotechnology market, Europe 23%, Canada 7%, Australia 3%, and the rest of the world, 2%.

Motivated research

Motivated research

Antoine Danchin

Abstract

Three years ago, a senior politician attended his country's Annual Congress for the Advancement of Science to give the introductory lecture. He asked the attending scientists to make science and research more attractive to young students and the general public, and asked his countrymen to support scientists to address the urgent challenges of global climate change, energy needs and dwindling water resources.

if you student or college in university  you must have

Motivated research for case ctuy, discustion and sharing

Press release Polaris Software Lab Limited (POLARIS.NS)(532254.BO)

ts release from http://www.businesswireindia.com if you share release gaian or new release you can email in here
Source: Polaris Software Lab Limited (POLARIS.NS)(532254.BO)
Wednesday, April 27, 2011 11:49 AM IST (06:19 AM GMT)
Editors: General: Economy; Business: Business services, Defence & security, Financial Analyst, Information technology, Stock exchanges; Technology

Polaris Enters Cloud Computing Space through Strategic Investment in IdenTrustTM
Investment in US-based Global Leader in Trusted Identity Solutions uniquely positions Polaris to drive the most robust digital security infrastructure in the US & European markets

Chennai, Tamil Nadu, India and New York, United States, Wednesday, April 27, 2011 -- (Business Wire India)


Polaris Software Lab Limited (POLS.BO), a leading global Financial Technology Company today announced a strategic investment in IdenTrustTM, a global leader in trusted identity solutions recognized by global financial institutions and one of the premier providers of digital identity authentication services to several key banks, United States federal identity programs as well as supply chain markets. This strategic investment will mark Polaris’ entry into the cloud computing space for Financial Technology solutions.

IdenTrust™ Inc. was founded in 1999 by a group of financial institutions that included Citigroup, Bank of America, Chase, Barclays, HSBC, and Deutsche. As the only bank-developed identity authentication system, IdenTrustTM provides a unique legally and technologically interoperable environment for authenticating and using identities worldwide. IdenTrustTM provides applications that use electronic identities that establish contracts, grant authority, support secure encrypted data and information storage and secure online interactions/transactions.